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Abstract 
Background and aims Limited evidence suggests habitual dairy consumption to be protective against 
metabolic syndrome (MetSyn) and type 2 diabetes among older adults. We assessed the association of 
baseline consumption of dairy products with the incidence of MetSyn and type 2 diabetes among a 
cohort of Australian adults aged 49 years and over. Methods and results A validated 145-item semi-
quantitative food frequency questionnaire was used to assess food and nutrient intake at baseline. Ten-
year incidence of MetSyn and type 2 diabetes were obtained from 1807 and 1824 subjects respectively. 
Odds ratios (OR) were calculated by discrete time logistic regression modelling. Compared with subjects 
in the lowest intake quartile of regular fat dairy products, those in the highest quartile had a 59% lower 
risk of MetSyn (multivariate adjusted OR: 0.41; 95% CI: 0.23-0.71; ptrend = 0.004), after adjustment for risk 
factors. Among obese subjects, an association between a high intake of regular fat dairy foods and 
reduced risk of type 2 diabetes was also found (age and sex adjusted OR 0.37; 95% CI: 0.16-0.88; ptrend = 
0.030), but the association did not persist after adjustment for additional confounders. There was no 
association between total dairy consumption and risk of MetSyn or type 2 diabetes. Conclusions We 
found an inverse association between regular fat dairy consumption and risk of MetSyn among Australian 
older adults. Further studies are warranted to examine the association between weight status, dairy 
consumption and risk of type 2 diabetes. 
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ABSTRACT 
BACKGROUND AND AIMS: Limited evidence suggests habitual dairy consumption to be 
protective against metabolic syndrome (MetSyn) and type 2 diabetes among older adults. We 
assessed the association of baseline consumption of dairy products with the incidence of MetSyn 
and type 2 diabetes among a cohort of Australian adults aged 49 years and over.  
METHODS AND RESULTS: A validated 145-item semi-quantitative food frequency 
questionnaire was used to assess food and nutrient intake at baseline. Ten-year incidence of 
MetSyn and type 2 diabetes were obtained from 1,807 and 1,824 subjects respectively. Odds 
ratios (OR) were calculated by discrete time logistic regression modelling. Compared with 
subjects in the lowest intake quartile of regular fat dairy products, those in the highest quartile 
had a 59% lower risk of MetSyn (multivariate adjusted OR: 0.41; 95% CI: 0.23-0.71; ptrend = 
0.004), after adjustment for risk factors. Among obese subjects, an association between a high 
intake of regular fat dairy foods and reduced risk of type 2 diabetes was also found (age and sex 
adjusted OR 0.37; 95%CI: 0.16-0.88; ptrend = 0.030), but the association did not persist after 
adjustment for additional confounders. There was no association between total dairy 
consumption and risk of MetSyn or type 2 diabetes. 
CONCLUSIONS: We found an inverse association between regular fat dairy consumption and 
risk of MetSyn among Australian older adults. Further studies are warranted to examine the 
association between weight status, dairy consumption and risk of type 2 diabetes.  
(240 words)
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INTRODUCTION 
Metabolic syndrome (MetSyn) and type 2 diabetes share common features such as abnormal 
glucose homeostasis, elevated blood lipids, and often central obesity. Indeed type 2 diabetes is 
considered a component of MetSyn by most international definitions [1-4]. MetSyn was deemed 
one of the fasting growing diseases in the world [5, 6]. Instead of a true syndrome, it is best 
described as a set of risk factors related to increased risks of cardiovascular diseases [7]. In 1999 
– 2000, it was estimated that around 29% of Australian adults aged 25 years or older had MetSyn 
[8].  
 
Diet and lifestyle changes are important in the prevention of MetSyn [9, 10] and type 2 diabetes 
[11, 12]. Among many foods that may offer protection against MetSyn or type 2 diabetes, dairy 
products are one of the most frequently investigated food groups. However, due to the paucity of 
prospective studies, evidence on the effects of dairy consumption on risk of MetSyn is 
inconclusive [13]. While the Hoorn study [14] in the Netherlands found no association between 
dairy consumption (regardless of type) and risk of MetSyn, other studies [7, 15, 16] suggested 
dairy intake was protective for MetSyn.  
 
Similarly,  some studies [5, 17] show no relationship between dairy consumption and risk of type 
2 diabetes but dairy consumption is generally considered to be protective of type 2 diabetes [12, 
18], mainly driven by the findings of large scale studies. In a study of 37.183 older women with 
an average follow up period of 10 years [19], a significant negative dose-dependent relationship 
between total dairy intake and type 2 diabetes incidence was found, although the protective 
effect was only seen amongst individuals without a family history of type 2 diabetes. On the 
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other hand, Choi et al [20] reported a protective effect of total dairy or low fat dairy amongst 41 
254 American males aged 40 – 70 y on type 2 diabetes, regardless of family history of diabetes.  
 
Overall, the limited evidence in older adults [7, 19, 20] suggests dairy consumption may be 
protective of MetSyn and/or type 2 diabetes in this age group. To the best of our knowledge no 
study had examined the effects of habitual dairy consumption and risk of these two conditions in 
older Australians. Here we report on the association between dairy consumption with the ten-
year incidence of MetSyn and type 2 diabetes in a relatively large cohort of Australians aged 49 
years and above.  
 
METHODS 
Study population 
The details of the Blue Mountains Eye Study (BMES) have been previously reported [21]. In 
brief, the BMES is a population-based cohort study of common eye diseases and other health 
conditions in residents aged 49 years and over in the Blue Mountains area, west of Sydney, 
Australia. Baseline information was obtained during 1992 – 1994. A total of 3 267 participants 
(89.4% of enrolled participants) attempted and returned the food frequency questionnaire (FFQ), 
of which 2 900 were usable (79.3% of participants examined). The details of the FFQ data 
cleaning process have been reported elsewhere [21]. At ten-years, in 2002-04, 1 824 people who 
provided complete FFQ data at baseline attended follow-up examinations including 
anthropometric and biochemical assessments, and were included in the present analysis.  
 
Dietary assessment 
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Dietary data were collected using a 145-item self-administered semi-quantitative FFQ, modified 
for the Australian diet and vernacular from an earlier FFQ by Willett et al [22]. Participants used 
a 9-category frequency scale to indicate the usual frequency of consuming individual food items 
during the past year. An allowance for seasonal variation of fruit and vegetables was made by 
weighting seasonal fruits and vegetables. Dietary intakes were reassessed by the same FFQ every 
5 years. The validity of the FFQ has been reported elsewhere [23, 24]. The Spearman correlation 
coefficient for total calcium was 0.61, with 71% of calcium results ranked within one quintile 
when compared to the weighed food records (WFR) and only 1% of calcium results were grossly 
misclassified (i.e. ranked highest by FFQ method and lowest by WFR method, or vice-versa). 
Published glycemic index (GI) values [25] were assigned to the food items in the FFQ, and the 
dietary GI and glycemic load (GL) were calculated for each subject as
and  respectively, where GIi is the GI (as percentage) of the i
th food, and CHOi is 
the amount of available carbohydrates in a serving of the ith food.   
 
Nutritional analysis 
Nutrient intakes were estimated using the Australian Tables of Food Composition (NUTTAB90) 
[26] for the dietary data. Foods listed in the FFQ were categorised into major food categories and 
subcategories similar to those used for the 1995 Australian National Nutrition Survey [27]. Dairy 
sub-categorisation includes regular milk, reduced fat/skim milk, low fat cheese, regular cheese, 
reduced fat dairy dessert (e.g. low fat yoghurt), and medium fat dairy dessert (e.g. custard and 
regular yoghurt). For the purpose of this analysis, total dairy included all of the aforementioned 
dairy foods; low/reduced fat dairy included ‘reduced fat/skim milk’, ‘reduced fat dairy dessert’ 
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and ‘low fat cheese’; while regular fat dairy included ‘regular milk’, ‘regular cheese’ and 
‘medium fat dairy dessert’. Quartiles of dairy product consumption were based on serves of dairy 
consumed per day. The serving sizes used were 250 g for milk, 200 g for yoghurt, 250 mL for 
custards, and 40 g for cheeses. A detailed list of food categories and subcategories used in the 
analyses can be found in Online Supplemental Table 1.  
 
Definitions of the health outcomes of interest 
Incidence of MetSyn was defined as obesity (BMI ≥ 30) and at least two of the following [4]:   
a) Elevated blood pressure: systolic BP ≥ 130 mmHg or diastolic BP ≥ 85 mmHg, or on 
anti-hypertensive medications, and/or; 
b) Triglycerides ≥ 1.7 mmol/L, and/or; 
c) HDL cholesterol: females < 1.29 mmol/L or males < 1.03 mmol/L, and/or 
d) Fasting blood glucose > 5.6 mmol/L or diagnosed T2DM. 
A fasting blood sample was used to assess blood triglycerides, HDL cholesterol and blood 
glucose, and blood pressure was measured on the day of the eye examination using standard 
auscultatory methods. Incidence of type 2 diabetes was defined as self-reported physician 
diagnosis of type 2 diabetes plus taking medication for type 2 diabetes; or fasting blood glucose 
≥ 7.0 mmol/L.  
 
Statistical analyses 
All statistical analyses were performed using SAS 9.1 (SAS Institute, Lane Cove, NSW, 
Australia). Of the 1 824 subjects who attended the examination at ten-years, 17 did not provide 
weight and/or height data and were excluded from analyses requiring BMI adjustment or 
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stratification. Trend for subject characteristics across quartiles were tested by linear regression 
for continuous variables. Pearson χ2 was used to test for difference between quartiles for 
categorical variables. Discrete time logistic regression modelling was used to investigate the 
associations between quartiles of total, regular fat and low/reduced fat dairy consumption and 
risk of MetSyn and type 2 diabetes, where change in dairy intake in the 10-y study period was 
taken intake account. There was no interaction between dairy intake and gender and smoking 
status and hence the results were not stratified based on these variables. The base model 
included adjustment for age and sex only. Model 1 was further adjusted for smoking status, 
physical activity (METs), dietary glycemic load, fibre from vegetables (g), total energy intake 
and family history of type 2 diabetes. Model 3 included all adjustments from Model 1, as well as 
systolic blood pressure (mmHg), BMI status (< 30 versus ≥ 30 kg/m2; in non-stratified analyses 
only), HDL cholesterol (mmol/L), total cholesterol (mmol/L) and triglyceride (mmol/L). Models 
2 and 4 included all adjustments from Models 1 and 3 respectively, plus additional adjustment 
for calcium (mg). Fibre from vegetables was used instead of total fibre as a previous study by our 
group had shown that this was the only type of fibre with a significant association to risk of type 
2 diabetes mellitus [28]. 
 
Ethics approval 
This study was conducted according to the guidelines laid down in the Declaration of Helsinki 
and all procedures involving human subjects/patients were approved by the Sydney West Area 
Health Service and University of Sydney Human Research Ethics Committees. Written, 
informed consent was obtained from all subjects/patients.  
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RESULTS 
The characteristics of the participants at baseline by quartiles of dairy intake are given in Online 
Supplemental Table 2. Participants who had higher total dairy intake had higher energy, 
calcium, total fat, saturated fat and vegetable fibre intake, dietary GL, as well as lower dietary GI 
(all ptrend < 0.001). Similar trends existed for quartiles of regular fat dairy consumption except for 
dietary GI, and there were more male (ptrend < 0.001) and smokers (ptrend = 0.020) in the higher 
quartiles. For low/reduced fat dairy, there were less male participants and smokers (both ptrend < 
0.001) in the higher quartiles. Those who consumed more low/reduced fat dairy had higher 
energy (ptrend = 0.003), calcium (ptrend < 0.001) and vegetable fibre intakes (ptrend = 0.005), but 
lower intakes of total fat and saturated fat, as well as dietary GI (all ptrend < 0.001). There was no 
difference between the history of cardiovascular diseases of the subjects across the quartiles. 
 
Table 1 shows the odds ratios of incident MetSyn according to quartiles of dairy intake. Subjects 
in the highest intake quartile of regular fat dairy at baseline had a significantly lower risk of 
MetSyn (Model 1: multivariate adjusted odds ratios (OR): 0.41; 95% confidence intervals (CI): 
0.23 – 0.71; ptrend = 0.004). The association remains after further adjustment for calcium (Model 
2: multivariate adjusted OR: 0.39; 95%CI: 0.22 – 0.70; ptrend = 0.004). No significant 
associations between baseline total dairy consumption and ten-year incidence of MetSyn were 
observed in any of the models tested. Subjects who had a higher intake of low/reduced fat dairy 
had an increased risk of MetSyn in the fully adjusted model (Model 2; ptrend = 0.043). There were 
no significant associations or trends between dairy consumption (total, low/reduced fat or regular 
fat) and risk of type 2 diabetes (Online Supplemental Table 3).  
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We further stratified the analyses by baseline BMI status (Online Supplemental Table 4), in the 
base model obese subjects in the highest quartile of regular fat dairy intake were found to be at a 
significantly reduced risk of type 2 diabetes (age and sex adjusted OR: 0.37; 95%CI: 0.16 – 
0.88), and a significant trend was also observed (ptrend = 0.030). However, these associations did 
not persist after adjustment for confounders, or exclusion of the 14% of subjects who switch 
BMI category in the 10-year follow-up period (data not shown). No associations between total or 
low/reduced fat dairy intake and type 2 diabetes were observed among obese or non-obese 
subjects. 
 
DISCUSSION 
To our best knowledge this is the first Australian longitudinal study to examine the relationship 
between dairy food consumption and risk of incident MetSyn and type 2 diabetes. This study 
found that in a population-based cohort of older Australians, people who consumed 
approximately two serves of regular fat dairy compared to those who consumed less than one 
serve of regular fat dairy (median serve of lowest quartile = 0.1), had a ~59% reduced risk of 
developing MetSyn, a relationship not observed with total or low/reduced fat dairy consumption. 
There was also a significant association between regular fat dairy consumption and risk of type 2 
diabetes amongst obese subjects but not in non-obese subjects. 
 
We found that in the BMES population, an increased low/reduced fat dairy intake was associated 
with a lower daily saturated fat intake, which is protective against various components of 
MetSyn such as high triglycerides and hyperlipidemia. Our finding of an increase in risk of 
MetSyn among those who had higher intakes of low / reduced fat dairy (i.e. 3rd and 4th quartile) 
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is therefore surprising. A recent study has found that daily consumption of low fat dairy products 
for 8 weeks did not improve metabolic markers related to MetSyn except for a slight decrease in 
systolic blood pressure [29], which may partly explain our results.  
 
Due to its higher saturated fat content, regular fat / high fat dairy products were previously 
believed to increase the risk of type 2 diabetes as a high saturated fat intake is associated with 
insulin resistance [12, 30]. However, cohort studies and a meta-analysis now suggest otherwise, 
with higher regular fat / high fat dairy consumption being considered mostly neutral or protective 
for type 2 diabetes [18-20]. The results of the present study are consistent with these findings 
that higher regular fat dairy consumption may be protective of MetSyn and type 2 diabetes. The 
potential harmful effects of higher saturated fat from regular fat dairy products may have been 
offset by the protective components of regular fat dairy [31], such as trans-palmitoleate, a fatty 
acid nearly unique to ruminant foods [32, 33]. Circulating level of trans-palmitoleate was shown 
to be significantly associated with reduced risk of type 2 diabetes (Q5 vs Q1: 62% reduced risk, 
95% CI: 38 – 76%, ptrend < 0.001) [32]. Moreover, the protective effect of trans-palmitoleate may 
be exerted via the suppression of hepatic fat synthesis, where the latter was strongly associated 
with insulin resistance [32, 34]. 
 
The association between dairy intake and ten-year incidence of type 2 diabetes could be 
mediated by weight status. Pereira et al [15] found that dairy consumption was associated with a 
reduced risk of abnormal glucose homeostasis only among subjects who were overweight at 
baseline. In agreement, we found a decreasing trend in risk of type 2 diabetes with increasing 
baseline intake of regular fat dairy only among obese subjects. However, these results must be 
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interpreted with caution due to the small numbers of obese subjects in this subgroup. As 
suggested by Pereira et al [15], subjects who were of normal weight at baseline may have a 
healthier lifestyle or genetic factors which protect them from getting diabetes, and being 
overweight is associated with a greater propensity to develop type 2 diabetes. In addition, 
subjects at higher risk of type 2 diabetes may have been advised by healthcare professionals to 
switch from regular fat to low/reduced fat dairy and lose weight. It has previously been shown 
that higher low/reduced fat dairy intake, in conjunction with an energy restricted diet, may 
promote higher weight loss and reduce waist circumference [35], which may reduce the risk of 
type 2 diabetes. In the present study 14% of the subjects have switched BMI categories in the 10 
year follow-up, however the results did not significantly change when these subjects were 
excluded from the analyses. 
 
Further this protective effect observed in obese subjects did not persist after additional 
adjustment for confounding variables and calcium. Dairy products are primary sources of 
calcium in the Australian diet. While it is possible that dietary calcium may be responsible for 
the protective effect of dairy consumption [16, 36], the loss in significance could also be due to a 
loss of statistical power due to the large number of adjustments made as well as the relatively 
small number of cases in the weight sub-groups.  
 
The strengths of this study include the use of a validated FFQ with a high correlation coefficient 
for calcium to assess the dairy consumption of the participants. This is likely to increase the 
plausibility of the associations found. The use of a well defined and generally accepted definition 
for MetSyn increased the reliability of the incidence data. The long follow up period also 
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allowed us to better capture the incidence of MetSyn and type 2 diabetes which take many years 
to develop. The present study was, however, limited by the relatively small sample size and the 
low incidence of type 2 diabetes, therefore, we cannot rule out the possibility of chance findings. 
Furthermore, we are unable to rule out the possibility of residual confounding from other 
lifestyle risk factors for MetSyn and/or type 2 diabetes. In addition, the use of self-reported 
physician diagnosis may have resulted in some cases of undiagnosed type 2 diabetes, although 
this chance was minimized by the additional fasting blood glucose level criterion. While a 75-g 
oral glucose tolerance test is considered to be the gold standard of diabetes diagnosis in the 
clinical setting, due to the high costs and effort associated, it is not feasible and not commonly 
used in large scale epidemiological studies. 
 
In conclusion, we found an inverse association between regular fat dairy consumption and risk of 
MetSyn among Australian older adults. Further studies are warranted to examine the association 
between weight status, dairy consumption and risk of type 2 diabetes.  
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Table 1 - Odds ratios (95% Confidence Intervals) of incident metabolic syndrome according to 
quartiles of reduced/low fat, regular fat and total dairy product intake 
 Q1 (ref) Q2 Q3 Q4 P for trend 
Total dairy      
n / cases 451 / 38 452 / 47 452 / 33 452 / 37 - 
aBase model 1.00 1.26 (0.81 – 1.95) 0.82 (0.51 – 
1.32) 
0.96 (0.60 – 
1.52) 
0.516 
bModel 1 1.00 1.21 (0.77 – 1.90) 0.72 (0.43 – 
1.20) 
0.86 (0.51 – 
1.44) 
0.332 
cModel 2 1.00 1.12 (0.68 – 1.83) 0.62 (0.33 – 
1.16) 
0.62 (0.24 – 
1.62) 
0.242 
Reduced/low fat dairy 
n / cases 465 / 22 438 / 38 459 / 54 445 / 41 - 
aBase model 1.00 1.63 (0.95 – 2.81) 2.44 (1.46 – 
4.07) 
1.79 (1.05 – 
3.07) 
0.121 
bModel 1 1.00 1.50 (0.86 – 2.60) 2.33 (1.39 – 
3.91) 
1.66 (0.95 – 
2.89) 
0.170 
cModel 2 1.00 1.50 (0.86 – 2.61) 2.45 (1.45 – 
4.13) 
2.01 (1.05 – 
3.83) 
0.043 
Regular fat dairy 
n / cases 436 / 45 467 / 41 456 / 44 448 / 25 - 
aBase model 1.00 0.83 (0.54 – 1.29) 0.91 (0.59 – 
1.40) 
0.52 (0.62 – 
0.86) 
0.018 
bModel 1 1.00 0.71 (0.45 – 1.13) 0.76 (0.48 – 
1.20) 
0.41 (0.23 – 
0.71) 
0.004 
cModel 2 1.00 0.71 (0.45 – 1.12) 0.76 (0.48 – 
1.20) 
0.39 (0.22 – 
0.70) 
0.004 
aBase model adjusted for age and sex 
bModel 1: Base model with additional adjustments for smoking status, physical activity (metabolic 
equivalents), dietary glycemic load, fibre from vegetables (g), total energy intake and family history of 
type 2 diabetes 
cModel 2: Model 1 with additional adjustment for calcium (mg) 
 
Online Supplemental Table 2 – Subject characteristics at baseline by quartiles of dairy intake  
 Q1 Q2 Q3 Q4 p valuea
Total dairy      
 Median intake (serves) 0.5 1.2 1.8 3.1 - 
  n  455 461 452 456 - 
  Age (y) 63.8 ± 8.5 63.5 ± 8.1 63.4 ± 8.3 63.9 ± 8.1 0.780 
  Male (%)  45.1 44.3 37.0 42.1 0.059 
  Smokers (%) 13.2 12.4 11.4 11.1 0.760 
  BMI (kg/m2) 26.0 ± 4.5 26.3 ± 4.3 26.2 ± 4.1 26.2 ± 4.0 0.745 
  Energy (kJ) 7288.8 ± 2358.4 7923.7 ± 2134.2 8873.8 ± 2334.5 10167.4 ± 2567.5 <0.001 
  Calcium (mg) 483.0 ± 166.1 717.4 ± 136.3 962.7 ± 160.0 1461.0 ± 331.4 <0.001 
  Total fat (g) 63.3 ± 25.9 69.4 ± 23.7 79.3 ± 26.1 91.7 ± 32.7 <0.001 
  Saturated fat (g) 23.1 ± 11.1 26.4 ± 10.2 31.2 ± 11.6 38.0 ± 16.1 <0.001 
  Vegetable fibre (g) 9.2 ± 4.7 9.6 ± 4.0 10.7 ± 4.4 11.1 ± 5.2 <0.001 
  Glycemic index 58.6 ± 4.8 56.8 ± 4.0 55.7 ± 3.8 54.3 ± 3.9 <0.001 
  Glycemic load 118.8 ± 44.3 126.3 ± 39.1 137.9 ± 44.6 153.8 ± 45.7 <0.001 
  Medical history of      
    CHD (%) 17.8 15.0 17.5 14.7 0.473 
    Hypertension (%) 55.4 49.3 49.7 50.7 0.228 
    AMI (%) 10.3 7.7 8.7 10.0 0.510 
    Angina (%) 14.3 11.7 14.4 11.2 0.337 
    Stroke (%) 5.4 5.1 5.3 6.7 0.723 
Low / reduced fat       
 Median intake (serves) 0.0 0.1 0.9 2.1 - 
  n  452 460 458 454 - 
  Age (y) 65.1 ± 8.8 62.1 ± 8.4 63.7 ± 8.0 63.8 ± 7.6 0.805 
  Male (%)  55.8 40.2 41.5 31.1 <0.001 
  Smokers (%) 16.6 15.2 9.2 7.2 <0.001 
  BMI (kg/m2) 25.7 ± 4.1 26.3 ± 4.4 26.4 ± 4.2 26.2 ± 4.2 0.283 
  Energy (kJ) 8812.4 ± 2659.1 8147.5 ± 2685.0 8335.6 ± 2511.8 8959.6 ± 2414.2 0.003 
  Calcium (mg) 773.3 ± 366.4  717.6 ± 343.1 853.1 ± 286.8 1279.8 ± 422.7 <0.001 
  Total fat (g) 82.3 ± 30.1 75.6 ± 30.3 73.0 ± 29.5 72.8 ± 26.3 <0.001 
  Saturated fat (g) 34.1 ± 14.7 29.8 ± 14.0 27.4 ± 12.7 27.4 ± 12.0 <0.001 
  Vegetable fibre (g) 9.9 ± 5.1 9.9 ± 4.8 10.1 ± 4.4 10.6 ± 4.1 0.005 
  Glycemic index 58.3 ± 4.7 57.0 ± 4.5 56.1 ± 3.7 54.0 ± 3.6 <0.001 
  Glycemic load 138.1 ± 48.0 126.0 ± 46.1 130.7 ± 42.0 141.9 ± 43.9 0.089 
  Medical history of      
    CHD (%) 17.0 16.7 16.0 15.3 0.901 
    Hypertension (%) 52.5 51.7 50.1 50.8 0.898 
    AMI (%) 9.7 9.2 8.6 9.3 0.947 
    Angina (%) 14.0 13.5 11.6 12.4 0.693 
    Stroke (%) 
 
 
 
 
 
4.3 5.8 5.5 7.0 0.369 
Regular fat       
 Median intake (serves) 0.1 0.4 1.0 1.9 - 
  n  454 457 442 471 - 
  Age (y) 63.6 ± 7.8 64.0 ± 8.1 63.4 ± 8.4 63.6 ± 8.8 0.746 
 Q1 Q2 Q3 Q4 p valuea
  Male (%)  35.7 39.8 44.3 48.4 <0.001 
  Smokers (%) 11.1 10.5 10.2 16.1 0.020 
  BMI (kg/m2) 26.1 ± 4.3 26.1 ± 4.3 26.2 ± 4.3 26.2 ± 3.9 0.782 
  Energy (kJ) 7312.7 ± 2309.2 8141.2 ± 2241.0 8718.5 ± 2391.8 10026.6 ± 2603.5 <0.001 
  Calcium (mg) 705.8 ± 380.7 848.8 ± 404.4 856.8 ± 308.4 1198.9 ± 409.9 <0.001 
  Total fat (g) 58.2 ± 23.1 69.0 ± 24.3 78.3 ± 25.1 97.4 ± 29.0 <0.001 
  Saturated fat (g) 20.1 ± 9.4 25.6 ± 10.3 30.6 ± 10.5 41.9 ± 13.3 <0.001 
  Vegetable fibre (g) 9.3 ± 4.2 10.1 ± 4.2 10.2 ± 4.6 10.9 ± 5.3 <0.001 
  Glycemic index 56.6 ± 4.6 56.3 ± 4.4 56.5 ± 4.5 56.0 ± 4.2 0.084 
  Glycemic load 122.5 ± 44.3 129.2 ± 41.3 135.0 ± 43.9 149.4 ± 47.6 <0.001 
  Medical history of      
    CHD (%) 16.3 15.2 18.4 15.1 0.494 
    Hypertension (%) 51.8 54.6 48.9 49.7 0.304 
    AMI (%) 8.6 9.7 9.2 9.2 0.951 
    Angina (%) 12.4 11.4 15.8 12.0 0.182 
    Stroke (%) 5.1 6.9 5.1 5.4 0.590 
Values are expressed as mean ± SD except specified otherwise. 
ap for trend tested by linear regression for continuous variables, and p value were tested by Pearson’s χ2 for 
categorical variables. 
CHD – coronary heart diseases; AMI – acute myocardial infarction 
 
Online Supplemental Table 3 - Odds ratios (95% Confidence Intervals) of incident type 2 diabetes 
according to quartiles of reduced/low fat, regular fat and total dairy product intake 
 Q1 (ref) Q2 Q3 Q4 P for trend 
Total dairy      
n / cases 455 / 35 461 / 47 452 / 30 456 / 33 - 
aBase model 1.00 1.33 (0.85 – 2.09) 0.80 (0.49 – 1.32) 0.90 (0.55 – 1.46) 0.310 
bModel 3 1.00 1.15 (0.71 – 1.87) 0.80 (0.46 – 1.40) 0.96 (0.54 – 1.71) 0.710 
cModel 4 1.00 1.29 (0.74 – 2.26) 1.00 (0.47 – 2.11) 1.50 (0.47 – 4.77) 0.568 
Reduced/low fat dairy 
n / cases 452 / 32 460 / 44 458 / 33 454 / 36 - 
aBase model 1.00 1.28 (0.79 – 2.05) 0.93 (0.56 – 1.53) 1.00 (0.61 – 1.64) 0.482 
bModel 3 1.00 1.29 (0.77 – 2.14) 0.85 (0.49 – 1.46) 1.00 (0.58 – 1.71) 0.482 
cModel 4 1.00 1.28 (0.77 – 2.14) 0.87 (0.50 – 1.52) 1.09 (0.57 – 2.09) 0.764 
Regular fat dairy 
n / cases 454 / 41 457 / 37 442 / 39 471 / 28 - 
aBase model 1.00 0.89 (0.56 – 1.41) 0.97 (0.62 – 1.53) 0.65 (0.40 – 1.07) 0.106 
bModel 3 1.00 1.02 (0.62 – 1.69) 1.01 (0.61 – 1.67) 0.83 (0.47 – 1.48) 0.496 
cModel 4 1.00 1.04 (0.63 – 1.72) 1.01 (0.61 – 1.68) 0.87 (0.48 – 1.57) 0.596 
aBase model adjusted for age and sex 
bModel 3: Model 1 with additional adjustments for systolic blood pressure (mmHg), baseline BMI status (< 30 
vs ≥ 30 kg/m2), HDL cholesterol (mmol/L), total cholesterol (mmol/L) and triglyceride (mmol/L).   
cModel 4: Model 3 with additional adjustment for calcium (mg) 
 
 
Online Supplemental Table 4 – Odds ratios (95% Confidence Intervals) of type 2 diabetes mellitus according to quartiles of reduced/low fat, regular fat and total 
dairy product intake, stratified by baseline BMI status 
Type of 
dairy 
BMI < 30 BMI ≥ 30 
Q1 
(ref) Q2 Q3 Q4 
P for 
trend
Q1 
(ref) Q2 Q3 Q4 
P for 
trend 
Total dairy  
 n / case 378 / 21 376 / 26 374 / 22 384 / 24 - 74 / 13 79 / 20         73 / 8 69 / 9 - 
aBase model 1.00 1.23 (0.68 – 2.21) 0.98 (0.54 – 1.81) 1.06 (0.59 – 1.93) 0.970 1.00 1.62 (0.77 – 3.41) 0.60 (0.24 – 1.50) 0.74 (0.30 – 1.81) 0.220 
bModel 3 1.00 1.10 (0.58– 2.05) 1.18 (0.61 – 2.28) 1.17 (0.59 – 2.36) 0.664 1.00 1.02 (0.44 – 2.36) 0.29 (0.10 – 0.88) 0.45 (0.15 – 1.34) 0.078 
cModel 4 1.00 1.04 (0.52 – 2.08) 1.07 (0.45 – 2.54) 0.96 (0.25 – 3.76) 0.952 1.00 2.16 (0.71 – 6.53) 1.03 (0.21– 4.97) 4.78 (0.44 – 52.47) 0.288 
Reduced fat and/or low fat 
 n / case 389 / 22 374 / 26 374 / 19 375 / 26 - 61 / 10 81 / 17 80 / 13 73 / 10 - 
aBase model 1.00 1.15 (0.64 – 2.06) 0.80 (0.43 – 1.50) 1.06 (0.59 – 1.92) 0.903 1.00 1.24 (0.53 – 2.88) 0.99 (0.41 – 2.38) 0.84 (0.33 – 2.14) 0.438 
bModel 3 1.00 1.14 (0.61 – 2.15) 0.73 (0.37 – 1.43) 1.02 (0.54 – 1.92) 0.763 1.00 1.50 (0.58 – 3.86) 1.09 (0.42 – 2.85) 0.73 (0.25 – 2.09) 0.230 
cModel 4 1.00 1.15 (0.61 – 2.16) 0.70 (0.35 – 1.38) 0.86 (0.40 – 1.85) 0.413 1.00 1.67 (0.64 – 4.38) 1.72 (0.62 – 4.78) 1.73 (0.49 – 6.13) 0.622 
Regular fat 
 n / case 366 / 22 387 / 24 372 / 27 387 / 20 - 82 / 19 65 / 11 69 / 12 79 / 8 - 
aBase model 1.00 1.05 (0.58 – 1.89) 1.25 (0.70 – 2.22) 0.89 (0.48 – 1.65) 0.708 1.00 0.68 (0.31 – 1.50) 0.66 (0.31 – 1.43) 0.37 (0.16 – 0.88) 0.030 
bModel 3 1.00 1.23 (0.65 – 2.30) 1.40 (0.73 – 2.66) 1.30 (0.64 – 2.68) 0.509 1.00 0.88 (0.36 – 2.16) 0.65 (0.27 – 1.59) 0.42 (0.15 – 1.19) 0.079 
cModel 4 1.00 1.21 (0.65 – 2.28) 1.40 (0.73 – 2.65) 1.25 (0.60 – 2.62) 0.580 1.00 1.02 (0.41 – 2.54) 0.64 (0.26 – 1.58) 0.57 (0.20 – 1.65) 0.201 
BMI – Body mass index 
aBase model adjusted for age and sex 
bModel 3: Model 1 with additional adjustments for systolic blood pressure (mmHg), HDL cholesterol (mmol/L), total cholesterol (mmol/L) and triglyceride (mmol/L).   
cModel 4: Model 3 with additional adjustment for calcium (mg) 
 
